Supernus Pharmaceuticals
SUPN
#5037
Rank
NZ$3.15 B
Marketcap
NZ$54.22
Share price
1.78%
Change (1 day)
-33.66%
Change (1 year)

Market capitalization of Supernus Pharmaceuticals (SUPN)

Market cap: NZ$3.15 Billion

As of November 2026 Supernus Pharmaceuticals has a market cap of NZ$3.15 Billion. This makes Supernus Pharmaceuticals the world's 5037th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Supernus Pharmaceuticals from 2012 to 2026

End of year Market Cap

Year Marketcap Change
2026NZ$3.15 B-38.16%
2025NZ$5.10 B40.25%
2024NZ$3.64 B45.61%
2023NZ$2.50 B-17.68%
2022NZ$3.03 B33.77%
2021NZ$2.27 B23.15%
2020NZ$1.84 B-0.36%
2019NZ$1.85 B-28.59%
2018NZ$2.59 B-9.92%
2017NZ$2.87 B59.28%
2016NZ$1.80 B87.65%
2015NZ$0.96 B111.39%
2014NZ$0.45 B24.09%
2013NZ$0.36 B37.46%
2012NZ$0.26 B

End of Day market cap according to different sources

On Nov 20th, 2026 the market cap of Supernus Pharmaceuticals was reported to be:

NZ$10.84 Billion
by Nasdaq info icon info icon
NZ$3.15 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
NZ$1.187 T 37,519.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
NZ$325.44 B 10,207.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$2.189 T 69,229.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$219.27 B 6,844.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Zogenix
ZGNX
NZ$2.73 B-13.32%๐Ÿ‡บ๐Ÿ‡ธ USA
United Therapeutics
UTHR
NZ$43.10 B 1,265.02%๐Ÿ‡บ๐Ÿ‡ธ USA